We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Genome Mining Technique Furthers Biologic Discovery

By LabMedica International staff writers
Posted on 26 Oct 2011
A newly developed method for microscopically extracting, or “mining,” data from genomes could represent a considerable boost in the search for new therapeutic drugs and improve the understanding of basic functions such as how cells communicate with one another. More...


Analyzing marine and terrestrial samples obtained from Alaska to San Diego’s La Jolla Cove, a research technique jointly created by scientists from the University of California San Diego (UCSD) Scripps Institution of Oceanography (La Jolla, USA) and Skaggs School of Pharmacy and Pharmaceutical Sciences at UCSD (CA, USA) and their colleagues taps powerful laboratory instruments to trace promising chemical compounds back to their genomic roots. The study’s findings were published the October 9, 2011, online publication of the journal Nature Chemical Biology.

Graduate student Roland Kersten developed a technique that utilizes mass spectrometry, a mass-analyzing application that decodes the composition and size of molecules, to reveal core structural features of genomes. “With only very small amounts of crude sample material, the mass spectrometer is able to fragment the unknown peptide into individual amino acid building blocks, so we can then map those to the genome level,” said Dr. Kersten, who works jointly in Dr. Pieter Dorrestein’s laboratory at the School of Pharmacy and Dr. Brad Moore’s lab at the Scripps Center for Marine Biotechnology and Biomedicine. “That provides us information about how to reassemble the molecule.”
Knowing such details through this genomic mining approach gives scientists a way to connect the natural chemicals generated by organisms back to the enzymes that construct them. These biosynthetic pathways are considered very valuable data in the search for new pharmaceuticals to treat diseases.

Using the new method, the scientists have already discovered two new classes of peptides, compounds comprised of amino acids that serve in functions ranging from communication to protection. “This represents a paradigm shift in the way that natural products are discovered and characterized, and it’s fundamentally different than what’s been practiced for the past decades in this field,” said Dr. Moore, a professor at Scripps and the Skaggs School of Pharmacy and Pharmaceutical Sciences at UCSD. “This has the capability of really changing the way natural products, or simply chemicals, are discovered in nature.”

The researchers are working on ways to automate the process to analyze biological samples faster. They believe the new technique will streamline the discovery of promising natural products. “We’re trying to bring up the speed of discovery in chemistry,” said Dr. Moore. “There’s a huge amount of information that’s out there and we are only scratching the surface-we’d like to dig a little deeper.”

“My UC San Diego colleague Bill Gerwick often states that natural products are a part of central dogma following DNA, RNA and proteins,” said Dr. Dorrestein. “I agree with Bill, natural products and related chemistries control biology yet these molecules are difficult to characterize. The tools for characterizing the molecules that control biology have not kept pace with modern science. The thought process introduced in this manuscript provides the foundation for finally bringing the fourth branch of central dogma into the realm of modern life sciences.”

Related Links:
Scripps Institution of Oceanography
Skaggs School of Pharmacy and Pharmaceutical Sciences


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.